LMNA-RELATED DILATED CARDIOMYOPATHY

Clinical trials for LMNA-RELATED DILATED CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new LMNA-RELATED DILATED CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for LMNA-RELATED DILATED CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Gene therapy trial aims to fix heart muscle in rare genetic disease

Disease control Not yet recruiting

This early-stage trial tests a single dose of a gene therapy called NVC-001 in 21 adults with a genetic form of dilated cardiomyopathy (LMNA mutation). The therapy uses a harmless virus to deliver a modified gene into heart cells, aiming to protect the heart muscle. The main goal…

Matched conditions: LMNA-RELATED DILATED CARDIOMYOPATHY

Phase: PHASE1, PHASE2 • Sponsor: Nuevocor Pte. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC

LMNA-RELATED DILATED CARDIOMYOPATHY

Get alerted when new LMNA-RELATED DILATED CARDIOMYOPATHY trials appear

Gene therapy trial aims to fix heart muscle in rare genetic disease